论文信息 - Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial - 字舞流文

Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial

M. Griesshammer | P. Guglielmelli | F. Passamonti | G. Saydam | S. Şıvgın | J. Callum | T. Devos | G. Benevolo | Mahmudul Khan | F. Palandri | M. Egyed | C. Bensasson | J. P. Ronco